Overview

The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC)

Status:
Terminated

Trial end date:
2011-06-01

Target enrollment:

Participant gender:

Summary

Primary goal of the study is to assess the overall survival of the addition of hypofractionated image guided radiotherapy concurrently with Docetaxel and cisplatin. Survival will be assessed at 1 year from the date of study enrollment to date of death.

Phase:

Phase 2

Details

Lead Sponsor:

University of Chicago

Treatments:

Cisplatin
Docetaxel